192 related articles for article (PubMed ID: 30287919)
1. Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.
Bajor M; Zych AO; Graczyk-Jarzynka A; Muchowicz A; Firczuk M; Trzeciak L; Gaj P; Domagala A; Siernicka M; Zagozdzon A; Siedlecki P; Kniotek M; O'Leary PC; Golab J; Zagozdzon R
Br J Cancer; 2018 Oct; 119(7):873-884. PubMed ID: 30287919
[TBL] [Abstract][Full Text] [Related]
2. Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.
Siernicka M; Winiarska M; Bajor M; Firczuk M; Muchowicz A; Bobrowicz M; Fauriat C; Golab J; Olive D; Zagozdzon R
Immunology; 2015 Sep; 146(1):173-83. PubMed ID: 26094816
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells.
Goncalves K; Sullivan K; Phelan S
Cancer Invest; 2012 Jan; 30(1):38-47. PubMed ID: 22236188
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.
O'Leary PC; Terrile M; Bajor M; Gaj P; Hennessy BT; Mills GB; Zagozdzon A; O'Connor DP; Brennan DJ; Connor K; Li J; Gonzalez-Angulo AM; Sun HD; Pu JX; Pontén F; Uhlén M; Jirström K; Nowis DA; Crown JP; Zagozdzon R; Gallagher WM
Breast Cancer Res; 2014 Jul; 16(4):R79. PubMed ID: 25011585
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin 1 plays a primary role in protecting pancreatic β-cells from hydrogen peroxide and peroxynitrite.
Stancill JS; Happ JT; Broniowska KA; Hogg N; Corbett JA
Am J Physiol Regul Integr Comp Physiol; 2020 May; 318(5):R1004-R1013. PubMed ID: 32292063
[TBL] [Abstract][Full Text] [Related]
6. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
[TBL] [Abstract][Full Text] [Related]
7. Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation.
Kalinina EV; Berezov TT; Shtil' AA; Chernov NN; Glazunova VA; Novichkova MD; Nurmuradov NK
Bull Exp Biol Med; 2012 Oct; 153(6):878-81. PubMed ID: 23113308
[TBL] [Abstract][Full Text] [Related]
8. Pro-Apoptotic Effects of JDA-202, a Novel Natural Diterpenoid, on Esophageal Cancer Through Targeting Peroxiredoxin I.
Shi XJ; Ding L; Zhou W; Ji Y; Wang J; Wang H; Ma Y; Jiang G; Tang K; Ke Y; Zhao W; Liu HM
Antioxid Redox Signal; 2017 Jul; 27(2):73-92. PubMed ID: 27650197
[TBL] [Abstract][Full Text] [Related]
9. Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells.
Bajor M; Graczyk-Jarzynka A; Marhelava K; Kurkowiak M; Rahman A; Aura C; Russell N; Zych AO; Firczuk M; Winiarska M; Gallagher WM; Zagozdzon R
Antioxidants (Basel); 2020 Apr; 9(4):. PubMed ID: 32316111
[TBL] [Abstract][Full Text] [Related]
10. PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.
Klopotowska M; Bajor M; Graczyk-Jarzynka A; Kraft A; Pilch Z; Zhylko A; Firczuk M; Baranowska I; Lazniewski M; Plewczynski D; Goral A; Soroczynska K; Domagala J; Marhelava K; Slusarczyk A; Retecki K; Ramji K; Krawczyk M; Temples MN; Sharma B; Lachota M; Netskar H; Malmberg KJ; Zagozdzon R; Winiarska M
Cancer Immunol Res; 2022 Feb; 10(2):228-244. PubMed ID: 34853030
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.
Hoshino I; Matsubara H; Hanari N; Mori M; Nishimori T; Yoneyama Y; Akutsu Y; Sakata H; Matsushita K; Seki N; Ochiai T
Clin Cancer Res; 2005 Nov; 11(21):7945-52. PubMed ID: 16278420
[TBL] [Abstract][Full Text] [Related]
12. Peroxiredoxin overexpression in MCF-7 breast cancer cells and regulation by cell proliferation and oxidative stress.
Tehan L; Taparra K; Phelan S
Cancer Invest; 2013 Jul; 31(6):374-84. PubMed ID: 23758190
[TBL] [Abstract][Full Text] [Related]
13. Prdx1-encoded peroxiredoxin is important for vascular development in zebrafish.
Huang PC; Chiu CC; Chang HW; Wang YS; Syue HH; Song YC; Weng ZH; Tai MH; Wu CY
FEBS Lett; 2017 Mar; 591(6):889-902. PubMed ID: 28231391
[TBL] [Abstract][Full Text] [Related]
14. A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7.
Hopkins BL; Nadler M; Skoko JJ; Bertomeu T; Pelosi A; Shafaei PM; Levine K; Schempf A; Pennarun B; Yang B; Datta D; Bucur O; Ndebele K; Oesterreich S; Yang D; Giulia Rizzo M; Khosravi-Far R; Neumann CA
Antioxid Redox Signal; 2018 Jan; 28(1):62-77. PubMed ID: 28398822
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin-1 Tyr194 phosphorylation regulates LOX-dependent extracellular matrix remodelling in breast cancer.
Attaran S; Skoko JJ; Hopkins BL; Wright MK; Wood LE; Asan A; Woo HA; Feinberg A; Neumann CA
Br J Cancer; 2021 Oct; 125(8):1146-1157. PubMed ID: 34389806
[TBL] [Abstract][Full Text] [Related]
16. Conoidin A, a Covalent Inhibitor of Peroxiredoxin 2, Reduces Growth of Glioblastoma Cells by Triggering ROS Production.
Szeliga M; Rola R
Cells; 2023 Jul; 12(15):. PubMed ID: 37566013
[TBL] [Abstract][Full Text] [Related]
17. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs.
Stresing V; Baltziskueta E; Rubio N; Blanco J; Arriba MC; Valls J; Janier M; Clézardin P; Sanz-Pamplona R; Nieva C; Marro M; Petrov D; Sierra A
Oncogene; 2013 Feb; 32(6):724-35. PubMed ID: 22430214
[TBL] [Abstract][Full Text] [Related]
18. Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux.
Jeong SJ; Kim S; Park JG; Jung IH; Lee MN; Jeon S; Kweon HY; Yu DY; Lee SH; Jang Y; Kang SW; Han KH; Miller YI; Park YM; Cheong C; Choi JH; Oh GT
Autophagy; 2018; 14(1):120-133. PubMed ID: 28605287
[TBL] [Abstract][Full Text] [Related]
19. Dual role of PRDX1 in redox-regulation and tumorigenesis: Past and future.
Guan X; Ruan Y; Che X; Feng W
Free Radic Biol Med; 2024 Jan; 210():120-129. PubMed ID: 37977211
[TBL] [Abstract][Full Text] [Related]
20. The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinases.
Jezierska-Drutel A; Attaran S; Hopkins BL; Skoko JJ; Rosenzweig SA; Neumann CA
BMC Cancer; 2019 Aug; 19(1):812. PubMed ID: 31419957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
